Headache News and Research

Latest Headache News and Research

PCR testing for B. burgdorferi bacteria in joint fluid may confirm Lyme arthritis diagnosis

New research shows that polymerase chain reaction testing for Borrelia burgdorferi DNA—the spirochetal bacteria transmitted by deer ticks—in joint fluid may confirm the diagnosis of Lyme arthritis, but is not a reliable indicator for active joint infection in patients whose arthritis persists after antibiotic therapy. Findings of this study are published in Arthritis & Rheumatism, a journal of the American College of Rheumatology.

13 May 2011

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

Doctors in Germany are among the first to treat ischemic stroke patients outside the United States with the REVIVE SE, a new self-expanding blood clot retrieval and removal device designed to remove blood clots and restore blood flow to the brain in patients having a stroke.

12 May 2011

Miltenyi Biotec enters partnership with TeutoCell to develop novel cell culture techniques

Miltenyi Biotec, the only company to offer a seamless experimental integration path from sample preparation through cell separation, culture, and analysis for primary cells, today entered into a strategic alliance with TeutoCell, a provider of cutting edge cell culture technology.

12 May 2011

ViroPharma, Halozyme sign license deal to develop Cinryze against hereditary angioedema

Halozyme Therapeutics, Inc. and ViroPharma Incorporated, today announced the signing of a worldwide exclusive licensing agreement for the use of rHuPH20 in the development of a subcutaneous formulation of Cinryze .

12 May 2011

Injecting botox in 'trigger points' of pericraneal and neck muscles reduces migraine frequency

Scientists at the University of Granada have confirmed that injecting a local anesthetic or botulinum toxin (botox) into certain points named "trigger points" of the pericraneal and neck muscles reduce migraine frequency among migraine sufferers. University of Granada researchers have identified the location of these trigger points -which activation results in migraine- and their relationship with the duration and severity of this condition.

11 May 2011

Ideal psychotropic drug may cause physical dependence

A report in the current issue of Psychotherapy and Psychosomatics by a group of European investigators headed by Fabrizio Schifano has explored the potential for dependence of pregabalin using patients' online reports.

9 May 2011

Period of observation can avoid unnecessary head CT scan use in children

Overall, roughly half of U.S. children taken to hospital emergency departments for a head injury receive a head CT scan, often to ease worried parents' concerns. Yet true traumatic brain injury is uncommon.

9 May 2011

Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting

Millennium: The Takeda Oncology Company today reported the presentation of results of a randomized Phase III trial that investigated the effect of consolidation with single-agent VELCADE for Injection in newly diagnosed multiple myeloma patients after autologous stem cell transplant.

7 May 2011

FDA approves Afinitor for treatment of progressive neuroendocrine tumors in the pancreas

On Thursday, the U.S. Food and Drug Administration approved Afinitor (everolimus) to treat patients with progressive neuroendocrine tumors located in the pancreas (PNET) that cannot be removed by surgery or that have spread to other parts of the body (metastatic).

7 May 2011

Survey: Only 12% of black stroke patients call 9-1-1 after experiencing symptoms

Most African-Americans say they'd call 9-1-1 if stroke symptoms occurred — but few do, according to research reported in Stroke: Journal of the American Heart Association.

6 May 2011

Millennium presents three studies in relapsed multiple myeloma at IMW meeting

Millennium: The Takeda Oncology Company today reported results from three studies in relapsed multiple myeloma. Two of the studies examined the use of VELCADE for Injection; the third study presents clinical data on MLN9708, the first investigational oral proteasome inhibitor.

6 May 2011

AHRQ finds 3 million hospital emergency visits for headaches during 2008

More than 3 million Americans went to hospital emergency rooms seeking relief from headaches and there were 81,000 hospitals admissions, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

6 May 2011

FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration approved Afinitor tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin in patients with unresectable, locally advanced or metastatic disease.

6 May 2011

Acorda reports $0.7 million GAAP net loss for first quarter 2011

Acorda Therapeutics, Inc. today announced its financial results for the first quarter ended March 31, 2011.

5 May 2011

POZEN reports revenue of $4.5 million for first quarter 2011

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the first quarter ended March 31, 2011.

5 May 2011

Headache disorders prevalent but under-treated and cause financial burden, WHO report says

Approximately half to three quarters of adults ages 18 to 65 experienced headache last year, making headache disorders one of the most prevalent but under-treated health problems in the world, according to a report released Tuesday by the WHO, Xinhua reports.

5 May 2011

South Australian man succumbs to Murray Valley Encephalitis

A 27-year-old South Australian Riverland man has succumbed to Murray Valley Encephalitis (MVE) – a viral disease that is carried by mosquitoes. According to SA Health's chief medical officer Paddy Phillips, the man had been receiving hospital care for MVE since March.

3 May 2011

Affinium announces AFN-1252 Phase I study results in staphylococcal infections

Affinium Pharmaceuticals announced today the results of a new multiple ascending dose Phase I study of its novel, selective-spectrum, anti-staphylococcal agent, AFN-1252 in a novel oral formulation.

3 May 2011

Scientists discover new gene underlying angle-closure glaucoma

Jackson Laboratory researchers and their collaborators have reported their discovery of a gene implicated in an acute and severe form of glaucoma known as angle-closure glaucoma.

3 May 2011

AstraZeneca receives FDA approval for NEXIUM I.V. to treat GERD with erosive esophagitis

AstraZeneca announced today that the U.S. Food and Drug Administration has approved the use of NEXIUM I.V. for Injection for children ages greater than 1 month old for the short-term treatment of gastroesophageal reflux disease with erosive esophagitis when oral therapy is not possible or appropriate.

3 May 2011

Headache News and Research

Latest Headache News and Research

PCR testing for B. burgdorferi bacteria in joint fluid may confirm Lyme arthritis diagnosis

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

Miltenyi Biotec enters partnership with TeutoCell to develop novel cell culture techniques

ViroPharma, Halozyme sign license deal to develop Cinryze against hereditary angioedema

Injecting botox in 'trigger points' of pericraneal and neck muscles reduces migraine frequency

Ideal psychotropic drug may cause physical dependence

Period of observation can avoid unnecessary head CT scan use in children

Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting

FDA approves Afinitor for treatment of progressive neuroendocrine tumors in the pancreas

Survey: Only 12% of black stroke patients call 9-1-1 after experiencing symptoms

Millennium presents three studies in relapsed multiple myeloma at IMW meeting

AHRQ finds 3 million hospital emergency visits for headaches during 2008

FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

Acorda reports $0.7 million GAAP net loss for first quarter 2011

POZEN reports revenue of $4.5 million for first quarter 2011

Headache disorders prevalent but under-treated and cause financial burden, WHO report says

South Australian man succumbs to Murray Valley Encephalitis

Affinium announces AFN-1252 Phase I study results in staphylococcal infections

Scientists discover new gene underlying angle-closure glaucoma

AstraZeneca receives FDA approval for NEXIUM I.V. to treat GERD with erosive esophagitis

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Headache News and Research

Latest Headache News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in